Last updated on March 2020

Safety Tolerability and Immunogenicity of V114 in Healthy Japanese Infants (V114-028)

Brief description of study

The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V114 administered subcutaneously or intramuscularly in healthy Japanese infants (3 months of age).

Clinical Study Identifier: NCT03848065

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.